Trial intelligence / Profile preview

Oliceridine for conscious endotracheal intubation in difficult airway

ChiCTR2400087374Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Chengdu Medical College
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of oliceridine in difficult airway (2 arms), sponsored by The First Affiliated Hospital of Chengdu Medical College. Primary endpoints: Hemodynamic indices, Ramsay Sedation Rating and 5 more. Planned start Jul 2024; status: not yet recruiting.

02

Drugs

oliceridine
03

Conditions

difficult airway

Beyond the preview

Go deeper on ChiCTR2400087374.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400087374.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call